Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
26.26
-0.10 (-0.38%)
At close: Jun 27, 2025, 2:57 PM CST
SHA:688161 Revenue
Shandong Weigao Orthopaedic Device had revenue of 290.19M CNY in the quarter ending March 31, 2025, a decrease of -16.59%. This brings the company's revenue in the last twelve months to 1.39B, up 12.35% year-over-year. In the year 2024, Shandong Weigao Orthopaedic Device had annual revenue of 1.45B with 13.18% growth.
Revenue (ttm)
1.39B
Revenue Growth
+12.35%
P/S Ratio
7.34
Revenue / Employee
675.21K
Employees
2,066
Market Cap
10.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.45B | 169.17M | 13.18% |
Dec 31, 2023 | 1.28B | -774.42M | -37.63% |
Dec 31, 2022 | 2.06B | -95.57M | -4.44% |
Dec 31, 2021 | 2.15B | 329.77M | 18.08% |
Dec 31, 2020 | 1.82B | 249.77M | 15.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |